Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, SQZ Biotechnologies Co's Enterprise Value is $12.75 Mil.
SQZ Biotechnologies Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-60.65 Mil. Therefore, SQZ Biotechnologies Co's EV-to-EBIT ratio for today is -0.21.
SQZ Biotechnologies Co Enterprise Value Historical Data
The historical data trend for SQZ Biotechnologies Co's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of SQZ Biotechnologies Co's Enterprise Value
For the Biotechnology subindustry, SQZ Biotechnologies Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SQZ Biotechnologies Co's Enterprise Value Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, SQZ Biotechnologies Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where SQZ Biotechnologies Co's Enterprise Value falls into.
SQZ Biotechnologies Co Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
SQZ Biotechnologies Co's Enterprise Value for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SQZ Biotechnologies Co (OTCPK:SQZB) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
SQZ Biotechnologies Co's current Enterprise Value is $12.75 Mil.
SQZ Biotechnologies Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-60.65 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
SQZ Biotechnologies Co's EV-to-EBITDA for today is:
SQZ Biotechnologies Co's current Enterprise Value is $12.75 Mil.
SQZ Biotechnologies Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-49.20 Mil.
SQZ Biotechnologies Co's current Enterprise Value is $12.75 Mil.
SQZ Biotechnologies Co's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $12.20 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SQZ Biotechnologies Co Enterprise Value Related Terms
Thank you for viewing the detailed overview of SQZ Biotechnologies Co's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
SQZ Biotechnologies Co (SQZ Biotechnologies Co) Business Description
SQZ Biotechnologies Co is a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. Using its proprietary technology, SQZ has the ability to deliver multiple materials into many patient cell types to engineer what it believes to be an unprecedented range of potential therapeutics for a range of diseases. The company has the potential to create well-tolerated cell therapies that can provide therapeutic benefit for patients and potentially improve the patient experience over existing cell therapy approaches, with accelerated production timelines under 24 hours and the elimination of preconditioning and lengthy hospital stays.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SQZB has been successfully added to your 